NFKB1 and colorectal carcinoma: In SW480 cells and an AOM/DSS-induced mouse CRC model, diallyl disulfide inhibits Glycogen synthase kinase-3β (GSK-3β), a positive regulator of NF-κB, thereby suppressing inflammation and tumors (45).